Vertex Pharmaceuticals’ JOURNA VX: Navigating Market Challenges Despite Promising ...
Needham analyst Joseph Stringer has maintained their neutral stance on VRTX stock, giving a Hold rating today.Invest with Confidence: Follow ...
Feeling sick? Here’s what to take and what to avoid, according to a doctor
CNN wellness expert Dr. Leana Wen suggests what to do to reduce your risk of catching respiratory viruses this winter and how to treat them if you’re sick.
Alaska Dispatch News13 小时
FDA approves new painkiller aimed at eliminating risks of addiction associated with opioids
WASHINGTON — Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and ...
FDA approves first new type of pain medication in 25 years
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
The Associated Press on MSN13 小时
FDA approves new painkiller that shows promise and challenges of opioid alternatives
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
US FDA Approves Vertex's Non-Opioid Painkiller
(Reuters) -The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health ...
Vertex Pharmaceuticals’ non-opioid Journavx approved for pain by FDA
Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class ...